Published in Liver Transpl on September 01, 2012
Liver transplantation: immunosuppression and oncology. Curr Opin Organ Transplant (2014) 0.94
Modulation of the autophagy pathway by human tumor viruses. Semin Cancer Biol (2013) 0.93
Changing the energy of an immune response. Am J Clin Exp Immunol (2013) 0.88
The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant (2014) 0.86
Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem. World J Gastroenterol (2014) 0.83
Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation. World J Hepatol (2015) 0.82
Review on immunosuppression in liver transplantation. World J Hepatol (2015) 0.79
Recurrent hepatitis C after liver transplant. World J Gastroenterol (2014) 0.79
Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances. J Clin Transl Hepatol (2014) 0.78
Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma. Liver Transpl (2016) 0.76
Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World J Gastroenterol (2014) 0.76
Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection. Clin Mol Hepatol (2016) 0.75
Optimization of immunosuppressive medication upon liver transplantation against HCC recurrence. Transl Gastroenterol Hepatol (2016) 0.75
Sirolimus: more cause for alarm? Liver Transpl (2012) 0.75
End of the line for sirolimus in liver transplant recipients with hepatitis C virus? Liver Transpl (2013) 0.75
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology (2011) 3.57
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Impact of multiple transarterial chemoembolization treatments on hepatocellular carcinoma for patients awaiting liver transplantation. Liver Transpl (2015) 2.63
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35
Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg (2005) 2.23
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus. Liver Transpl (2011) 1.85
JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J Biol Chem (2009) 1.82
Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology (2012) 1.70
Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl (2007) 1.64
Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection. Hepatology (2011) 1.59
Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels. Liver Transpl (2011) 1.58
Liver transplantation for cholangiocarcinoma. Transpl Int (2010) 1.58
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosis. J Hepatol (2010) 1.56
Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology (2011) 1.52
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology (2013) 1.50
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus-infected patients awaiting liver transplantation. Liver Transpl (2002) 1.45
Mycophenolate and hepatitis C: salve on a wound or gasoline on a fire? Liver Transpl (2002) 1.41
Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol (2002) 1.29
Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation. Liver Transpl (2005) 1.22
Long-term probability of and mortality from de novo malignancy after liver transplantation. Gastroenterology (2009) 1.18
Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol (2004) 1.17
Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl (2013) 1.16
Endoscopic ultrasound staging of cholangiocarcinoma. Curr Opin Gastroenterol (2012) 1.16
The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. Clin Infect Dis (2002) 1.13
The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population. Clin Gastroenterol Hepatol (2007) 1.13
Introduction to the genetics and biology of interleukin-28B. Hepatology (2012) 1.11
Free fatty acid storage in human visceral and subcutaneous adipose tissue: role of adipocyte proteins. Diabetes (2011) 1.09
Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am (2009) 1.08
The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables. Transplantation (2012) 1.08
Predicting failure of outpatient laparoscopic cholecystectomy. Am J Surg (2002) 1.08
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl (2002) 1.08
Metabolic syndrome and liver transplantation: a review and guide to management. J Hepatol (2010) 1.08
Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol (2010) 1.07
Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl (2015) 1.06
Nonalcoholic steatohepatitis (NASH) does not increase complications after laparoscopic bariatric surgery. Obes Surg (2011) 1.03
Liver transplantation for perihilar cholangiocarcinoma. Dig Dis (2013) 1.02
Diagnostic accuracy of split-night polysomnograms. J Clin Sleep Med (2010) 1.00
Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg (2012) 0.99
International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation (2016) 0.99
Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol (2010) 0.99
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J Lipid Res (2011) 0.98
Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis. Hepatology (2010) 0.98
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation. Liver Transpl (2014) 0.95
Patients with diabetes and depression may need additional support for exercise. Am J Health Behav (2006) 0.94
Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. Hepatology (2012) 0.93
Right hepatectomy for living liver donation vs right hepatectomy for disease: intraoperative and immediate postoperative comparison. Arch Surg (2007) 0.92
Pregnancy-associated acute liver disease and acute viral hepatitis: differentiation, course and outcome. J Hepatol (2008) 0.91
Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl (2002) 0.90
Nutrition in alcoholic liver disease. Clin Liver Dis (2012) 0.89
Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol (2005) 0.89
Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors. HPB (Oxford) (2014) 0.88
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol (2013) 0.87
Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg (2013) 0.87
Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: a systematic review and meta-analysis. Liver Transpl (2012) 0.87
Combined heart and liver transplantation: a single-center experience. Transplantation (2009) 0.84
Patient and graft outcomes from older living kidney donors are similar to those from younger donors despite lower GFR. Kidney Int (2004) 0.84
Aasld guidelines for the treatment of hepatocellular carcinoma. Hepatology (2017) 0.83
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review. Liver Transpl (2013) 0.83
Antibody-mediated rejection in liver transplantation: current controversies and future directions. Liver Transpl (2014) 0.83
APACHE III outcome prediction in patients admitted to the intensive care unit after liver transplantation: a retrospective cohort study. BMC Surg (2009) 0.83
Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int (2013) 0.82
Eosinophilic gastrointestinal disorders (EGID) with peripheral eosinophilia: a retrospective review at Mayo Clinic. Dig Dis Sci (2011) 0.82
Leadership and professionalism curriculum in the Gross Anatomy course. Ann Acad Med Singapore (2006) 0.82
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. Liver Transpl (2013) 0.81
Interleukin-28B polymorphism in hepatitis C and liver transplantation. Liver Transpl (2013) 0.81
Using implantation biopsies as a surrogate to evaluate selection criteria for living kidney donors. Transplantation (2013) 0.80
The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Liver Int (2013) 0.80
Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease? Hepatology (2014) 0.79
Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol (2005) 0.79
Posttransplant metabolic syndrome: new evidence of an epidemic and recommendations for management. Liver Transpl (2011) 0.79
Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview. Eur Respir Rev (2012) 0.79
Hypophosphatemia after right hepatectomy for living donor liver transplantation. Can J Gastroenterol (2004) 0.79
Early subclinical coronary artery calcification in young adults who were pediatric kidney transplant recipients. Am J Transplant (2005) 0.78
Frequency, clinical presentation, and outcomes of drug-induced liver injury after liver transplantation. Liver Transpl (2012) 0.78
Treatment of HCV prior to liver transplantation to prevent HCV recurrence - wise or wasteful? Liver Int (2015) 0.78
Antituberculosis therapy drug-induced liver injury and acute liver failure. Hepatology (2010) 0.78
Fibrosing NASH: on being a blind man in a dark room looking for a black cat (that isn't there). Gastroenterology (2010) 0.78
Characterization of hepatitis B virus surface antigen and polymerase mutations in liver transplant recipients pre- and post-transplant. Am J Transplant (2003) 0.78
Genes and transplant outcomes: the search for "associations". Transplantation (2014) 0.78
Survival benefit of liver transplantation: one size fits all or fits none? Hepatology (2009) 0.77
Serum albumin level is a notable profiling factor for non-B, non-C hepatitis virus-related hepatocellular carcinoma: A data-mining analysis. Hepatol Res (2013) 0.77
The International Liver Transplant Society Guideline on Living Liver Donation. Transplantation (2016) 0.77
Serum adipokine and inflammatory markers before and after liver transplantation in recipients with major cardiovascular events. Liver Transpl (2014) 0.76
Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation. Liver Transpl (2010) 0.76
Origin of adenocarcinoma in a transplanted liver determined by microsatellite analysis. Hum Pathol (2002) 0.76
Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma. Am J Clin Oncol (2016) 0.75